Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Iris Buchanan-Perry, MD, MSc, FAAP
Healthcare Provider Associate Professor
Morehouse School of Medicine
720 Westview Drive
Atlanta, Georgia, United States
Dr. Buchanan serves as a Clinical Instructor in patients with hemoglobinopathies. Dr Buchanan has been involved in clinical research and care of patients with Sickle Cell Disease locally and nationally. Experience in national clinical trials includes Props I, Pre-operative transfusion study and STOP. She has recently submitted a proposal for a national collaboration in the modulating effect of various opioids on the development of the acute chest syndrome in patients with sickle cell disease. Dr. Buchanan has been a member of the NIH Sickle Cell Disease advisory board and is presently a board member of the Sickle Cell Disease Association of America (SCDAA) and the Sickle Cell Foundation of Georgia. Recent training includes a master’s degree in epidemiology. Dr. Buchanan is the Co-Director of the Division of Pediatric Research as well as Director of Research for the MSM pediatric residents, which involves in the training of research principles and study design.
+myBinderRelated Content
-
Sickle Cell Disease: Racism in the American Health Care SystemWednesday, June 28 1-4 pm EDT Massachu...
-
Alecia Nero, MDA hematology specialist at UT Southweste...
-
Family functioning, medical self-management, and health outcomes among school-aged children with sickle cell disease...BACKGROUND: Informed by the Pediatric S...
-
Patrick T. McGann, MD, MSPatrick T. McGann, MD, is the Director o...
-
Children’s National Health SystemSickle cell disease affects many familie...
-
Gene-Therapy Company Crispr Drops as FDA Puts Trial on HoldCrispr Therapeutics AG plunged after the...
-
Executive functioning and health-related quality of life in pediatric sickle cell diseaseResearch consistently indicates that chi...
